CREB1 and Cognitive impairment: EGCG (2 g/day) upregulates IRS1/Akt and ERK/CREB/BDNF (brain-derived neurotrophic factor) signalling pathways, significantly decreasing IR and cognitive impairment in HFD and high-fructose-induced mouse models of cognitive impairment.